MarketPeel
Insider Trading Intelligence
Pricing
…
TA

Thomas Phd Adams

CRDF
EXECUTIVE CHAIRMAN · CARDIFF ONCOLOGY, INC. · CIK 0001234366
FILING MIX · LIFETIME100%/0%
BUYS
8
SELLS
0
TOTAL VALUE
$20.0K
COMPANIES
1
ACTIVE SINCE
May 2020
HOLDINGS NOW
477,870
AVG SELL PX
—
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Thomas Phd Adams, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+43.36%+3.48%+39.88%+39.88%—
14d1+100.00%+76.92%+6.31%+70.61%+70.61%—
30d1+100.00%+72.73%+6.75%+65.98%+65.98%—
60d1+100.00%+215.38%+10.96%+204.42%+204.42%—
90d1+100.00%+285.66%+18.93%+266.74%+266.74%—
180d1+100.00%+1112.59%+25.28%+1087.30%+1087.30%—
1y1+100.00%+497.90%+48.53%+449.38%+449.38%—
2y1+0.00%-6.29%+45.12%-51.41%-51.41%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CRDF · 477,870 shares · as of Jun 10, 2021
0119,468238,935358,403477,8702021SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
FLOW · 8 buys / 0 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
173,145——477,870Jun 10, 2021Jun 14, 2021 ↗
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
298,320——477,870Jun 10, 2021Jun 14, 2021 ↗
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
223——477,870Jun 10, 2021Jun 14, 2021 ↗
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
530——477,870Jun 10, 2021Jun 14, 2021 ↗
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
755——477,870Jun 10, 2021Jun 14, 2021 ↗
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
272——477,870Jun 10, 2021Jun 14, 2021 ↗
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
173,145——477,870Jun 17, 2020Jun 19, 2020 ↗
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
13,986$1.43$20.0K18,875May 14, 2020May 18, 2020 ↗
Other insiders · CRDF
Loading peer insiders…
About this filer
CIK 0001234366
ROLE
Executive Chairman
PRIMARY
CRDF
COMPANIES
1
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001234366DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback